Abstract:Nucleoside analogs have been widely used as antiviral, antitumor, and antiparasitic agents due to their ability to inhibit nucleic acid synthesis. Adenosine, cytidine, guanosine, thymidine and uridine analogs such as didanosine, vidarabine, remdesivir, gemcitabine, lamivudine, acyclovir, abacavir, zidovusine, stavudine, and idoxuridine showed remarkable anticancer and antiviral activities. In our previously published articles, our main intention was to develop newer generation nucleoside analogs with acylation-induced modification of the hydroxyl group and showcase their biological potencies. In the process of developing nucleoside analogs, in silico studies play an important role and provide a scientific background for biological data. Molecular interactions between drugs and receptors followed by assessment of their stability in physiological environments, help to optimize the drug development process and minimize the burden of unwanted synthesis. Computational approaches, such as DFT, FMO, MEP, ADMET prediction, PASS prediction, POM analysis, molecular docking, and molecular dynamics simulation, are the most popular tools to culminate all preclinical study data and deliver a molecule with maximum bioactivity and minimum toxicity. Although clinical drug trials are crucial for providing dosage recommendations, they can only indirectly provide mechanistic information through researchers for pathological, physiological, and pharmacological determinants. As a result, in silico approaches are increasingly used in drug discovery and development to provide mechanistic information of clinical value. This article portrays the current status of these methods and highlights some remarkable contributions to the development of nucleoside analogs with optimized bioactivity.

Recent Advances on Aza-Nucleoside Analogues

An Update Mini-Review on the Progress of Azanucleoside Analogues

Synthesis of Janus Type Nucleoside Analogues and Their Preliminary Bioactivity

Nucleoside Analogues as Anticancer Agents

The hydrazine moiety in the synthesis of modified nucleosides and nucleotides

Recent Advances in the Chemical Synthesis and Evaluation of Anticancer Nucleoside Analogues

Preparation,characterization and biological evaluation of azido-seconucleoside analogues

Synthesis and Antiviral Activities of Isonucleosides and Their Monophosphates

Recent Advance on Chemical Synthesis and Anti-Vzv Activity of Bicyclic Furo[2,3-D]pyrimidine Nucleoside

In Silico Pharmacokinetics, Molecular Docking and Molecular Dynamics Simulation Studies of Nucleoside Analogs for Drug Discovery- A Mini Review

Recent Developments in the Synthesis of N-aryl Sulfonamides

Novel Aryltriazole Acyclic C-azanucleosides As Anticancer Candidates

Modifications Of Aminogocoside Antibiotics Targeting Rna

Synthesis and biological evaluation of novel C6-amino substituted 4-azasteroidal purine nucleoside analogues

Synthesis of Fluorinated Nucleosides/Nucleotides and Their Antiviral Properties

Synthesis of 1,2,3- Triazole Nucleoside Analogues

Synthesis and in vitro anti-hepatitis B virus activity of six-membered azanucleoside analogues.

Modifications of Aminoglycoside Antibiotics Targeting RNA

Design and Synthesis of Bicyclo[4.3.0]nonene Nucleoside Analogues

Synthesis of Antiviral Acyclic C-nucleosides Incorporating 4-Thiazolinones Structure

Recent advances in antiviral activities and potential mechanisms of sulfated polysaccharides